Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 1202459, 13 pages
https://doi.org/10.1155/2017/1202459
Research Article

Testosterone Upregulates the Expression of Mitochondrial ND1 and ND4 and Alleviates the Oxidative Damage to the Nigrostriatal Dopaminergic System in Orchiectomized Rats

1Department of Neurobiology, Hebei Medical University, Shijiazhuang, Hebei 050017, China
2Department of Human Anatomy, Shijiazhuang Medical College, Shijiazhuang, Hebei 050599, China
3Department of Human Anatomy, Hebei Medical University, Shijiazhuang, Hebei 050017, China

Correspondence should be addressed to Geming Shi

Received 29 March 2017; Revised 1 August 2017; Accepted 7 August 2017; Published 24 August 2017

Academic Editor: Icksoo Lee

Copyright © 2017 Wensheng Yan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Gandhi and A. Y. Abramov, “Mechanism of oxidative stress in neurodegeneration,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 428010, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Manoharan, G. J. Guillemin, R. S. Abiramasundari, M. M. Essa, M. Akbar, and M. D. Akbar, “The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8590578, 15 pages, 2016. View at Publisher · View at Google Scholar
  3. E. Niedzielska, I. Smaga, M. Gawlik et al., “Oxidative stress in neurodegenerative diseases,” Molecular Neurobiology, vol. 53, no. 6, pp. 4094–4125, 2016. View at Publisher · View at Google Scholar
  4. W. Lv, N. Du, Y. Liu et al., “Low testosterone level and risk of Alzheimer’s disease in the elderly men: a systematic review and meta-analysis,” Molecular Neurobiology, vol. 53, no. 4, pp. 2679–2684, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ahlbom, G. S. Prins, and S. Ceccatelli, “Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism,” Brain Research, vol. 892, no. 2, pp. 255–262, 2001. View at Google Scholar
  6. S. Meydan, I. Kus, U. Tas et al., “Effects of testosterone on orchiectomy-induced oxidative damage in the rat hippocampus,” Journal of Chemical Neuroanatomy, vol. 40, no. 4, pp. 281–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. W. Son, J. S. Lee, H. G. Kim, D. W. Kim, Y. C. Ahn, and C. G. Son, “Testosterone depletion increases the susceptibility of brain tissue to oxidative damage in a restraint stress mouse model,” Journal of Neurochemistry, vol. 136, no. 1, pp. 106–117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. G. L. Zhang, W. Wang, Y. X. Kang et al., “Chronic testosterone propionate supplement could activated the Nrf2-ARE pathway in the brain and ameliorated the behaviors of aged rats,” Behavioural Brain Research, vol. 252, pp. 388–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Zhang, S. Li, Y. Kang et al., “Enhancement of dopaminergic activity and region-specific activation of Nrf2-ARE pathway by intranasal supplements of testosterone propionate in aged male rats,” Hormones and Behavior, vol. 80, pp. 103–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. K. A. Foster, F. Galeffi, F. J. Gerich, D. A. Turner, and M. Müller, “Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration,” Progress in Neurobiology, vol. 79, no. 3, pp. 136–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. R. Figueira, M. H. Barros, A. A. Camargo et al., “Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health,” Antioxidants & Redox Signaling, vol. 18, no. 16, pp. 2029–2074, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. I. E. Scheffler, “A century of mitochondrial research: achievements and perspectives,” Mitochondrion, vol. 1, no. 1, pp. 3–31, 2001. View at Google Scholar
  13. A. A. Starkov, “The role of mitochondria in reactive oxygen species metabolism and signaling,” Annals of the New York Academy of Sciences, vol. 1147, pp. 37–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Bonda, X. Wang, G. Perry, M. A. Smith, and X. Zhu, “Mitochondrial dynamics in Alzheimer’s disease: opportunities for future treatment strategies,” Drugs & Aging, vol. 27, no. 3, pp. 181–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. H. Reddy, “Mitochondrial medicine for aging and neurodegenerative diseases,” Neuromolecular Medicine, vol. 10, no. 4, pp. 291–315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Hattori, M. Tanaka, T. Ozawa, and Y. Mizuno, “Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson’s disease,” Annals of Neurology, vol. 30, no. 4, pp. 563–571, 1991. View at Google Scholar
  17. P. Mao and P. H. Reddy, “Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: implications for early intervention and therapeutics,” Biochimica et Biophysica Acta, vol. 1812, no. 11, pp. 1359–1370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial complex I deficiency in Parkinson’s disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Google Scholar
  19. A. H. Schapira, V. M. Mann, J. M. Cooper et al., “Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease,” Journal of Neurochemistry, vol. 55, no. 6, pp. 2142–2145, 1990. View at Google Scholar
  20. L. K. Sharma, J. Lu, and Y. Bai, “Mitochondrial respiratory complex I: structure, function and implication in human diseases,” Current Medicinal Chemistry, vol. 16, no. 10, pp. 1266–1277, 2009. View at Google Scholar
  21. K. F. Winklhofer and C. Haass, “Mitochondrial dysfunction in Parkinson’s disease,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 29–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. R. Cabello, J. J. Thune, H. Pakkenberg, and B. Pakkenberg, “Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy,” Neuropathology and Applied Neurobiology, vol. 28, no. 4, pp. 283–291, 2002. View at Google Scholar
  23. G. A. Gerhardt, W. A. Cass, A. Yi, Z. Zhang, and D. M. Gash, “Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys,” Journal of Neurochemistry, vol. 80, no. 1, pp. 168–177, 2002. View at Google Scholar
  24. J. W. Haycock, L. Becker, L. Ang, Y. Furukawa, O. Hornykiewicz, and S. J. Kish, “Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum,” Journal of Neurochemistry, vol. 87, no. 3, pp. 574–585, 2003. View at Google Scholar
  25. J. F. Marshall and A. J. Rosenstein, “Age-related decline in rat striatal dopamine metabolism is regionally homogeneous,” Neurobiology of Aging, vol. 11, no. 2, pp. 13–17, 1990. View at Google Scholar
  26. L. Chen, Y. Ding, B. Cagniard et al., “Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice,” The Journal of Neuroscience, vol. 28, no. 2, pp. 425–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Dias, E. Junn, and M. M. Mouradian, “The role of oxidative stress in Parkinson’s disease,” Journal of Parkinson’s Disease, vol. 3, no. 4, pp. 461–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Hwang, “Role of oxidative stress in Parkinson’s disease,” Experimental Neurobiology, vol. 22, no. 1, pp. 11–17, 2013. View at Publisher · View at Google Scholar
  29. L. S. Forno, “Neuropathology of Parkinson’s disease,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 3, pp. 259–272, 1996. View at Google Scholar
  30. J. D. Crane, M. C. Devries, A. Safdar, M. J. Hamadeh, and M. A. Tarnopolsky, “The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 65, no. 2, pp. 119–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Pesce, A. Cormio, F. Fracasso et al., “Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle,” Free Radical Biology & Medicine, vol. 30, no. 11, pp. 1223–1233, 2001. View at Google Scholar
  32. S. W. Lamberts, A. W. van den Beld, and A. J. van der Lely, “The endocrinology of aging,” Science, vol. 278, no. 5337, pp. 419–424, 1997. View at Google Scholar
  33. A. Vasconsuelo, L. Milanesi, and R. Boland, “Actions of 17β-estradiol and testosterone in the mitochondria and their implications in aging,” Ageing Research Reviews, vol. 12, no. 4, pp. 907–917, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. R. L. Cunningham, T. Macheda, L. T. Watts et al., “Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion,” Hormones and Behavior, vol. 60, no. 5, pp. 617–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Ghanadian, J. G. Lewis, and G. D. Chisholm, “Serum testosterone and dihydrotestosterone changes with age in rat,” Steroids, vol. 25, no. 6, pp. 753–762, 1975. View at Google Scholar
  36. S. M. Harman, E. J. Metter, J. D. Tobin, J. Pearson, and M. R. Blackman, “Longitudinal effects of aging on serum total and free testosterone levels in healthy men, Baltimore Longitudinal Study of Aging,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 724–731, 2001. View at Publisher · View at Google Scholar
  37. E. R. Rosario, L. Chang, E. H. Head, F. Z. Stanczyk, and C. J. Pike, “Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease,” Neurobiology of Aging, vol. 32, no. 4, pp. 604–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. T. Lin and M. F. Beal, “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases,” Nature, vol. 443, no. 7113, pp. 787–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Cui, G. Zhang, Y. Kang et al., “Amelioratory effects of testosterone propionate supplement on behavioral, biochemical and morphological parameters in aged rats,” Experimental Gerontology, vol. 47, no. 1, pp. 67–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Wang, Y. Kang, G. Zhang et al., “Deficits in coordinated motor behavior and in nigrostriatal dopaminergic system ameliorated and VMAT2 expression up-regulated in aged male rats by administration of testosterone propionate,” Experimental Gerontology, vol. 78, pp. 1–11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Zhang, G. Shi, H. Tan, Y. Kang, and H. Cui, “Intranasal administration of testosterone increased immobile-sniffing, exploratory behavior, motor behavior and grooming behavior in rats,” Hormones and Behavior, vol. 59, no. 4, pp. 477–483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Paxinos and C. Watson, “The rat brain in stereotaxic coordinates,” Tech. Rep., Academic Press, Orlando, FL, 2007. View at Google Scholar
  43. V. Chisu, P. Manca, G. Lepore, S. Gadau, M. Zedda, and V. Farina, “Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line,” Archives Italiennes de Biologie, vol. 144, no. 2, pp. 63–73, 2006. View at Google Scholar
  44. M. D. Spritzer, E. D. Daviau, M. K. Coneeny, S. M. Engelman, W. T. Prince, and K. N. Rodriguez-Wisdom, “Effects of testosterone on spatial learning and memory in adult male rats,” Hormones and Behavior, vol. 59, no. 4, pp. 484–496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. B. B. Yeap, Z. Hyde, O. P. Almeida et al., “Lower testosterone levels predict incident stroke and transient ischemic attack in older men,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 7, pp. 2353–2359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Estrada, A. Varshney, and B. E. Ehrlich, “Elevated testosterone induces apoptosis in neuronal cells,” The Journal of Biological Chemistry, vol. 281, no. 35, pp. 25492–25501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. A. Kamal, A. Gomaa, M. e. Khafif, and A. S. Hammad, “Plasma lipid peroxides among workers exposed to silica or asbestos dust,” Environmental Research, vol. 49, no. 2, pp. 173–180, 1989. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Melo, L. Monteiro, R. M. Lima, D. M. Oliveira, M. D. Cerqueira, and R. S. El-Bachá, “Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 467180, 14 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Cardenas-Rodriguez, B. Huerta-Gertrudis, L. Rivera-Espinosa et al., “Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1455–1476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Ruszkiewicz and J. Albrecht, “Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders,” Neurochemistry International, vol. 88, pp. 66–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. D. J. Bonda, X. Wang, G. Perry et al., “Oxidative stress in Alzheimer disease: a possibility for prevention,” Neuropharmacology, vol. 59, no. 4-5, pp. 290–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. H. A. Funes, N. Apostolova, F. Alegre et al., “Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz,” The Journal of Infectious Diseases, vol. 210, no. 9, pp. 1385–1395, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Poljsak, “Strategies for reducing or preventing the generation of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 194586, 15 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Ozawa, “Genetic and functional changes in mitochondria associated with aging,” Physiological Reviews, vol. 77, no. 2, pp. 425–464, 1997. View at Google Scholar
  55. D. C. Guzmán, G. B. Mejía, I. E. Vázquez, E. H. García, D. S. del Angel, and H. J. Olguín, “Effect of testosterone and steroids homologues on indolamines and lipid peroxidation in rat brain,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 94, no. 4, pp. 369–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Schloesser, T. Esatbeyoglu, S. Piegholdt et al., “Dietary tocotrienol/γ-cyclodextrin complex increases mitochondrial membrane potential and ATP concentrations in the brains of aged mice,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 789710, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Fornstedt, E. Pileblad, and A. Carlsson, “In vivo autoxidation of dopamine in guinea pig striatum increases with age,” Journal of Neurochemistry, vol. 55, no. 2, pp. 655–659, 1990. View at Google Scholar
  58. A. Slivka and G. Cohen, “Hydroxyl radical attack on dopamine,” The Journal of Biological Chemistry, vol. 260, no. 29, pp. 15466–15472, 1985. View at Google Scholar
  59. M. F. Kritzer, “Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat,” The Journal of Comparative Neurology, vol. 379, no. 2, pp. 247–260, 1997. View at Google Scholar
  60. R. B. Simerly, C. Chang, M. Muramatsu, and L. W. Swanson, “Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study,” The Journal of Comparative Neurology, vol. 294, no. 1, pp. 76–95, 1990. View at Publisher · View at Google Scholar · View at Scopus
  61. P. J. Shughrue, M. V. Lane, and I. Merchenthaler, “Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system,” The Journal of Comparative Neurology, vol. 388, no. 4, pp. 507–525, 1997. View at Google Scholar
  62. P. J. Shughrue and I. Merchenthaler, “Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system,” The Journal of Comparative Neurology, vol. 436, no. 1, pp. 64–81, 2001. View at Google Scholar
  63. M. Marella, B. B. Seo, T. Yagi, and A. Matsuno-Yagi, “Parkinson’s disease and mitochondrial complex I: a perspective on the Ndi1 therapy,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 6, pp. 493–497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Vartak, J. Deng, H. Fang, and Y. Bai, “Redefining the roles of mitochondrial DNA-encoded subunits in respiratory complex I assembly,” Biochimica et Biophysica Acta, vol. 1852, no. 7, pp. 1531–1539, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Okun, B. L. Walter, W. M. McDonald et al., “Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease,” Archives of Neurology, vol. 59, no. 11, pp. 1750–1753, 2002. View at Google Scholar
  66. R. E. Ready, J. Friedman, J. Grace, and H. Fernandez, “Testosterone deficiency and apathy in Parkinson’s disease: a pilot study,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 75, no. 9, pp. 1323–1326, 2004. View at Publisher · View at Google Scholar · View at Scopus